April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Importance Of Autoreactive Antibodies For Retinal Ganglion Cell Loss In A Model Of Experimental Autoimmune Glaucoma
Author Affiliations & Notes
  • Stephanie C. Joachim
    Center for Vision Science, Ruhr University, Bochum, Germany
  • Oliver W. Gramlich
    Experimental Ophthalmology, University Medical Center, Mainz, Mainz, Germany
  • Burkhard H. Dick
    Center for Vision Science, Ruhr University, Bochum, Germany
  • Sebastian Pirro
    Experimental Ophthalmology, University Medical Center, Mainz, Mainz, Germany
  • Panagoitis Laspas
    Experimental Ophthalmology, University Medical Center, Mainz, Mainz, Germany
  • Franz H. Grus
    Experimental Ophthalmology, University Medical Center, Mainz, Mainz, Germany
  • Footnotes
    Commercial Relationships  Stephanie C. Joachim, None; Oliver W. Gramlich, None; Burkhard H. Dick, None; Sebastian Pirro, None; Panagoitis Laspas, None; Franz H. Grus, None
  • Footnotes
    Support  Deutsche Forschungsgemeinschaft (DFG JO-886/1-1)
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2447. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Stephanie C. Joachim, Oliver W. Gramlich, Burkhard H. Dick, Sebastian Pirro, Panagoitis Laspas, Franz H. Grus; Importance Of Autoreactive Antibodies For Retinal Ganglion Cell Loss In A Model Of Experimental Autoimmune Glaucoma. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2447.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Antibodies against retinal antigens occur in patients with glaucoma. Previous studies using a model of experimental autoimmune glaucoma demonstrated that immunization with certain ocular antigens causes an immune-mediated retinal ganglion cell (RGC) loss in rodents.

Methods: : Lewis rats were immunized with a retinal ganglion cell layer homogenate (RGA, n=10) and compared to controls (CO, n=10). RGC density was quantified using cresyl stained retinal flatmounts after six weeks. Retina and optic nerve cross-sections were used for detection of autoreactive antibodies, antibody depositions, and microglia cells (via anti-Iba 1 antibody). Depositions and microglia were counted on all cross-sections. A scoring system, ranging from 0=no DAB staining to 3=strong staining, was applied for the intensity of the autoreactive antibody stain. A possible retinal gliosis was also analyzed, using anti-GFAP antibody. Severity of gliosis was scored by three examiners, scores ranging from 0=no staining, to 3=strong GFAP positive staining. The two groups were compared via t-test. Additionally, brain sections were analyzed for possible pathological findings.

Results: : Immunization with RGA did only lead to a reduced retinal ganglion cell density (p=0.007) but also to antibody deposits in the retina (RGA: 3.0±0.5/mm; CO=1.3±0.3/mm). An increase in autoreactive antibodies occurred in retinas after immunization, at six weeks a mean score of 4±0.3 was observed for the RGA group compared to 0.3±0.1 for controls (p=0.004). Additionally, we detected a reactive Müller cell gliosis (scores: RGA=2.03±0.1, CO=1.3±0.2; p=0.001) as well as the invasion of activated microglia cells (RGA: 6.3±0.9 cells/mm, CO: 2.2±0.2 cells/mm; p=0.005). Observations of the CNS revealed no pathological aberrations, such as inflammatory infiltrates, demyeliniation or hemorrhages.

Conclusions: : Our findings suggest that autoreactive antibodies play a substantial role in mechanisms leading to retinal ganglion cell death, possibly through binding to RGCs and therefore triggering apoptosis. RGC loss seems to lead to Müller cell activation as well as the invasion of activated microglia, which might be associated with debris clearance.

Keywords: ganglion cells • retinal glia • optic nerve 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×